Residues in the heptad repeat a region of the fusion protein modulate the virulence of Sendai virus in mice. Luque LE, Bridges OA, Mason JN, Boyd KL, Portner A, Russell CJ (2010) J Virol 84: 810-21 Recombinant Sendai virus expressing the G glycoprotein of respiratory syncytial virus (RSV) elicits immune protection against RSV. Takimoto T, Hurwitz JL, Coleclough C, Prouser C, Krishnamurthy S, Zhan X, Boyd K, Scroggs RA, Brown B, Nagai Y, Portner A, Slobod KS (2004) J Virol 78: 6043-7 The novel parainfluenza virus hemagglutinin-neuraminidase inhibitor BCX 2798 prevents lethal synergism between a paramyxovirus and Streptococcus pneumoniae. Alymova IV, Portner A, Takimoto T, Boyd KL, Babu YS, McCullers JA (2005) Antimicrob Agents Chemother 49: 398-405 Effect of hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 on growth and pathogenicity of Sendai/human parainfluenza type 3 chimera virus in mice. Watanabe M, Mishin VP, Brown SA, Russell CJ, Boyd K, Babu YS, Taylor G, Xiong X, Yan X, Portner A, Alymova IV (2009) Antimicrob Agents Chemother 53: 3942-51 Respiratory syncytial virus (RSV) fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in cotton rats and confers protection against RSV subtypes A and B. Zhan X, Hurwitz JL, Krishnamurthy S, Takimoto T, Boyd K, Scroggs RA, Surman S, Portner A, Slobod KS (2007) Vaccine 25: 8782-93 Recombinant Sendai virus as a novel vaccine candidate for respiratory syncytial virus. Takimoto T, Hurwitz JL, Zhan X, Krishnamurthy S, Prouser C, Brown B, Coleclough C, Boyd K, Scroggs RA, Portner A, Slobod KS (2005) Viral Immunol 18: 255-66
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.